Pharmacoeconomic aspects of warfarin and new oral anticoagulants use as prevention of thromboembolic complications in patients with atrial fibrillation. UJC [Internet]. 2020 Oct. 1 [cited 2025 Apr. 30];27(4):45-53. Available from: https://www.ucardioj.com.ua/index.php/UJC/article/view/229